What are the appropriate next steps after completing pulmonary function testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Next Steps After Pulmonary Function Testing

The immediate next step after completing pulmonary function testing is to systematically interpret the results by comparing them to reference values, identifying any ventilatory impairments, assessing severity, and determining whether specialist referral or additional testing is warranted based on specific thresholds. 1, 2

Systematic Interpretation Framework

Step 1: Assess Technical Quality and Validity

  • Verify test acceptability and reproducibility before proceeding with clinical interpretation, as poor-quality tests may reflect technical issues, equipment malfunction, or underlying disease rather than true pulmonary function 1
  • Confirm accuracy of demographic data (age, height, sex, ethnicity) since these directly affect reference value selection and interpretation 1
  • Consider repeating spirometry if results are not reproducible or quality is poor, which may itself indicate disease 1

Step 2: Compare Results to Reference Values

  • Determine if FVC, FEV1, and FEV1/FVC ratio are normal, low, or high by comparing to healthy reference populations 2
  • Use FEV1/FVC ratio <70% (or below 5th percentile) to identify obstructive defects in adults, or <85% in patients 5-18 years of age 3
  • Use FVC below 5th percentile (or <80% predicted in ages 5-18) to identify restrictive patterns 3

Step 3: Identify Specific Ventilatory Impairments

For Obstructive Pattern (Low FEV1/FVC):

  • Perform post-bronchodilator testing if not already done to determine reversibility: >12% and >200 mL increase in FEV1 in adults (or >12% in ages 5-18) indicates reversible disease like asthma 3
  • A low DLCO with obstruction greatly increases probability of emphysema phenotype COPD, while normal DLCO makes chronic asthma more likely 4
  • Post-bronchodilator FEV1 <80% predicted with FEV1/FVC <70% confirms COPD diagnosis per GOLD criteria, though this has 100% sensitivity but only 38% specificity for distinguishing COPD from asthma 5

For Restrictive Pattern (Low FVC with Normal FEV1/FVC):

  • Order full pulmonary function tests including DLCO and lung volumes to confirm restrictive lung disease and establish differential diagnosis 3
  • A low DLCO with restriction increases probability of interstitial lung disease, while normal DLCO makes chest wall restriction more likely 4
  • Check total lung capacity (TLC) from single-breath helium dilution during DLCO testing—a normal TLC rules out true restriction without requiring body plethysmography 4

For Mixed Pattern:

  • Both low FEV1/FVC ratio and low FVC indicate mixed defect requiring comprehensive evaluation 3

Step 4: Determine Disease Severity

  • Use FEV1 percentage predicted as the primary severity metric: ≥80% (mild), 50-79% (moderate), <50% (severe) 6
  • DLCO <40% predicted or decline >4 units is associated with increased morbidity and mortality and warrants aggressive management 4

Step 5: Specialist Referral Thresholds

Refer to pulmonologist when:

  • FVC 60-80% predicted, FEV1/FVC 50-70%, or pulse oximetry 90-93% (yellow zone requiring specialist evaluation) 1
  • FVC <60% predicted, FEV1/FVC <50%, or pulse oximetry <90% (red zone requiring urgent specialist referral) 1
  • More than 2 pneumonia episodes treated with antibiotics in last 5 years, or 1 episode requiring hospitalization 1
  • Low DLCO with normal spirometry (suggests pulmonary vascular disease or mild interstitial lung disease) 4
  • Resting hypoxemia detected on pulse oximetry, as this may indicate hypercapnia from thoracic cage restriction 1

Step 6: Advanced Testing by Pulmonologist

When referred, the pulmonologist should perform:

  • Chest X-ray when first seen to assess anatomy, restriction, and signs of chronic lung disease 1
  • Peak cough flow (PCF): if <160 mmHg, further intervention needed for inadequate cough clearance 1
  • Diffusing capacity (DLCO) after volume adjustment: if <90% predicted, further testing required 1
  • Complete lung volumes (TLC, RV/TLC, ERV) by plethysmography or washout if spirometry is abnormal or restrictive lung function/hyperinflation suspected 1
  • FEF25-75% to evaluate small airways function 1
  • Maximum inspiratory and expiratory pressures to assess respiratory muscle strength 1

Step 7: Longitudinal Monitoring

For serial testing:

  • Compare current results to previous baseline to detect disease progression 1
  • Calculate FEV1 decline rate: typical decline is ~29 mL/year in nonsmokers; >60-90 mL/year indicates accelerated decline associated with increased morbidity and mortality 1
  • A >15% decline in FEV1 after correcting for aging may indicate excessive decline requiring intervention 1
  • Use linear regression of all FEV1 data over time for reliable decline estimation after 5-8 years of follow-up 1

Step 8: Consider Additional Clinical Context

Integrate PFT results with:

  • Respiratory symptoms and their timing relative to work or exposures 1
  • Smoking history and cessation status 1
  • Weight changes, medication adherence, and inhaler technique 6
  • Sleep-related symptoms: if ≥2 positive responses to sleep questionnaire (daytime sleepiness, restlessness, difficulty waking, morning headaches), recommend sleep study 1

Common Pitfalls to Avoid

  • Do not proceed with forced expiratory maneuvers within 4-6 weeks of ocular surgery due to risk of increased intraocular pressure compromising surgical repair 7
  • Do not interpret "normal" predicted values in patients with skeletal abnormalities (e.g., osteogenesis imperfecta) without considering that prediction equations may overestimate function 1
  • Do not rely solely on spirometry for diagnosis—DLCO adds critical diagnostic information, particularly for distinguishing emphysema from asthma in obstructive disease and ILD from chest wall restriction in restrictive patterns 4
  • Do not ignore borderline abnormal results (FVC 60-80%, FEV1/FVC 50-70%, oxygen saturation 90-93%) as these warrant specialist evaluation 1
  • Maintain consistent testing conditions (same equipment, operator, time of day within 2 hours) for serial monitoring to ensure valid comparisons 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

COPD Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Safety of Pulmonary Function Testing After Recent Ocular Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the next step in managing a patient with a total lung capacity (TLC) of 123% and diffusing capacity of the lungs for carbon monoxide (DLCO) of 118%, who reports occasional shortness of breath (SOB) on exertion, and has not been seen since a previous date?
I am a current smoker with spirometry showing forced vital capacity 64% predicted, forced expiratory volume in one second 22% predicted, FEV1/FVC ratio 34%, forced expiratory flow 25‑75% predicted 17%, and diffusing capacity of the lung for carbon monoxide 48% predicted; what is the likely diagnosis and how should it be managed?
What is the best course of action for a patient with chronic chest discomfort, lung pain, normal DLCO, elevated FVC, and decreased FEV1/FVC ratio, suggestive of obstructive lung disease?
What is the likely diagnosis and management plan for a petite patient with initial mild obstructive defect, later normal Forced Expiratory Volume in 1 second (FEV1), mildly reduced Diffusing Capacity of the Lung for Carbon Monoxide (DLCO), and normal Total Lung Capacity (TLC) and Full Blood Count (FBC)?
What is the diagnosis and management plan for a patient with impaired lung function, as indicated by reduced Forced Expiratory Volume in 1 second (FEV1), Forced Expiratory Volume in 1 second/Forced Vital Capacity (FEV1/FVC) ratio, and diffusing capacity (DLCO)?
What non‑beta‑blocker medication can be used to treat essential tremor in an elderly male patient who is experiencing bradycardia from bisoprolol?
Can Dexona (dexamethasone) be used for acute management of a cervical spinal cord injury presenting with unilateral lower‑limb weakness?
For rate control of atrial fibrillation in a patient with asthma, chronic obstructive pulmonary disease, or peripheral vascular disease, is metoprolol (β1‑selective) preferred over propranolol (non‑selective)?
What is the recommended management of adynamic ileus?
In a patient with attention‑deficit/hyperactivity disorder, which stimulant medication has the least effect on blood pressure?
How should balanitis be treated, including hygiene measures, antifungal and antibacterial options, and management of recurrent cases?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.